The agency said the move reflected an updated analysis of the risk of a rare but serious blood-clotting condition in people who get the vaccine.
Author: SHARON LaFRANIERE
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}